Prism Medico Pharmacy Ltd vs Yash Management Satelite Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Prism Medico & Pharmacy Ltd is ₹ 31.52 as of 23 Oct 15:30 . The P/E Ratio of Prism Medico & Pharmacy Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Yash Management & Satelite Ltd changed from 16.8 on March 2021 to 127.2 on March 2026 . This represents a CAGR of 40.13% over 6 years The Market Cap of Prism Medico & Pharmacy Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Yash Management & Satelite Ltd changed from ₹ 23.75 crore on March 2021 to ₹ 12.97 crore on March 2026 . This represents a CAGR of -9.59% over 6 years The revenue of Prism Medico & Pharmacy Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Yash Management & Satelite Ltd for the Sep '26 is ₹ 11.52 crore as compare to the Jun '26 revenue of ₹ 10.54 crore. This represent the growth of 9.3% The ebitda of Prism Medico & Pharmacy Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Yash Management & Satelite Ltd for the Sep '26 is ₹ 0.34 crore as compare to the Jun '26 ebitda of ₹ 1.44 crore. This represent the decline of -76.39% The net profit of Prism Medico & Pharmacy Ltd changed from ₹ 0 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of 0.0% The net profit of Yash Management & Satelite Ltd changed from ₹ 0.95 crore to ₹ 0.41 crore over 10 quarters. This represents a CAGR of -28.55% The Dividend Payout of Prism Medico & Pharmacy Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Yash Management & Satelite Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Prism Medico & Pharmacy Ltd

Prism Medico and Pharmacy Limited was originally incorporated under the name of Woolite Mercantile Company Limited on 21st February, 1985.
The name of the Company was changed from Woolite Mercantile Company Limited to Prism Medico and Pharmacy Limited dated January 9, 2012.
Initially, the Company was engaged into Wholesale and Retail of straw, fodder and other animal/poultry feed.
It also engaged into investments, share trading, and financial activities. Over the past years, the Company was not able to carry out any major operations, resulting it engaged in trading. During FY 2022-23, the main objects of the Memorandum of Association of the Company were altered so as to manufacture, formulate, process, develop, refine, import, export, wholesale and/or retail trade all kinds of pharmaceuticals, antibiotics, drugs, medicines, biological, neutraceuticals, healthcare, ayurvedic and dietary supplement products, medicinal preparations, vaccines, chemicals, chemical products, dry salters, mineral waters, wines, cordials, liquors, soups, broths and other restoratives or foods and also to deal in medicinal goods.

About Yash Management & Satelite Ltd

Yash Management & Satellite Limited was initially incorporated as Yash Management & Financial Services Limited on August 4, 1993.
Name of the Company was changed to Yash Management & Satellite Limited during the year 1999-2000. In 1999-2000, the Company diversified its activities in the field of Entertainment, Media, Films studios and Television Software.
In a major development it started a post production studio titled 'YASH STUDIO' at Juhu in Mumbai, the entertainment hub of the Bollywood by acquiring hitech equipments for editing and sound recording. In 2004-05, the Company got into Memorandum of Understanding (MOU) with Cientifica Ltd. UK for providing services in the field of Nanotechnology in India.
It signed agreements with Indian Institute of Technology, Bombay (NT Bombay), National Chemical Laboratory, Pune (NCL Pune) and Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore(JNCASR Bangalore).

FAQs for the comparison of Prism Medico & Pharmacy Ltd and Yash Management & Satelite Ltd

Which company has a larger market capitalization, Prism Medico & Pharmacy Ltd or Yash Management & Satelite Ltd?

Market cap of Prism Medico & Pharmacy Ltd is 42 Cr while Market cap of Yash Management & Satelite Ltd is 17 Cr

What are the key factors driving the stock performance of Prism Medico & Pharmacy Ltd and Yash Management & Satelite Ltd?

The stock performance of Prism Medico & Pharmacy Ltd and Yash Management & Satelite Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Prism Medico & Pharmacy Ltd and Yash Management & Satelite Ltd?

As of October 25, 2026, the Prism Medico & Pharmacy Ltd stock price is INR ₹31.52. On the other hand, Yash Management & Satelite Ltd stock price is INR ₹10.16.

How do dividend payouts of Prism Medico & Pharmacy Ltd and Yash Management & Satelite Ltd compare?

To compare the dividend payouts of Prism Medico & Pharmacy Ltd and Yash Management & Satelite Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.